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Abstract
Background: Severe fever with thrombocytopenia syndrome is an emerging infectious disease caused by a novel
phlebovirus belonging to the family Bunyaviridate. Emergence of encephalitis/encephalopathy during severe fever
with thrombocytopenia syndrome progression has been identified as a major risk factor associated with a poor
prognosis. Here we report the case of a severely ill patient with severe fever with thrombocytopenia syndrome
virus-associated encephalitis/encephalopathy characterized by a lesion of the splenium, which resolved later.
Case presentation: A 56-year-old Japanese man presented with fever and diarrhea, followed by dysarthria. Diffusion-
weighted magnetic resonance imaging demonstrated high signal intensity in the splenium of the corpus callosum.
The severe fever with thrombocytopenia syndrome virus genome was detected in our patient’s serum, and the clinical
course was characterized by convulsion, stupor, and hemorrhagic manifestations, with disseminated intravascular
coagulation and hemophagocytic lymphohistiocytosis. Supportive therapy not including administration of
corticosteroids led to gradual improvement of the clinical and laboratory findings, and magnetic resonance
imaging demonstrated resolution of the splenial lesion. The serum severe fever with thrombocytopenia syndrome viral
copy number, which was determined with the quantitative reverse-transcription polymerase chain reaction, rapidly
decreased despite the severe clinical course. Our patient’s overall condition improved, allowing him to be eventually
discharged.
Conclusions: Patients with encephalitis/encephalopathy due to severe fever with thrombocytopenia syndrome virus
infection may have a favorable outcome, even if they exhibit splenial lesions and a severe clinical course; monitoring
the serum viral load may be of value for prediction of outcome and potentially enables the avoidance of
corticosteroids to intentionally cause opportunistic infection.
Keywords: Severe fever with thrombocytopenia syndrome, Encephalitis/encephalopathy, Reversible splenial
lesion syndrome, Serum viral load, Case report
Background
Severe fever with thrombocytopenia syndrome (SFTS)
is a recently identified infectious disease endemic to
China, South Korea, and Japan, with a reported fatality
rate between 12% and 30% [1]. The emergence of cen-
tral nervous system (CNS) manifestations during SFTS
progression has been identified as a major risk factor
for mortality [2].
The presence of reversible lesions that involve the
splenium of the corpus callosum (SCC) has been re-
ported in patients with a broad spectrum of diseases and
conditions and is referred to as reversible splenial lesion
syndrome (RESLES) [3]. The magnetic resonance imaging
(MRI) features of RESLES include reversible lesions limited
to the splenium of the corpus callosum (SCC) or to the
SCC and frontal white matter; hyperintense signals on T2-
weighted images (T2WI), fluid-attenuated inversion
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recovery (FLAIR) images and diffusion-weighted images
(DWI); with low apparent diffusion coefficient (ADC)
values and hypo- or iso-intense signals on T1-weighted
imaging (T1WI) sequences with no contrast enhancement
[4, 5].
The exact pathophysiology and the specific site predi-
lection of transient SCC lesions in RESLES are not
understood. It has been suggested that transient SCC le-
sions likely reflect rapidly resolving intramyelinic edema
or the influx of inflammatory cells and macromolecules,
combined with related cytotoxic edema and hypotonic
hyponatremia, which result from infection [6–8].
Here we report the case of a severely ill patient with
SFTS virus-associated encephalitis/encephalopathy in
whom follow-up magnetic resonance imaging (MRI)
demonstrated a lesion in the SCC. This lesion eventually
resolved, and our patient made a complete clinical re-
covery within a few weeks. Analysis of the SFTS viral
load in our patient’s serum during hospitalization
demonstrated a rapid decrease.
Case presentation
A 56-year-old Japanese man, who had been engaged in
agricultural activities in a hilly rural area of Japan, pre-
sented to a local hospital in August, with a 2-day history
of fever and diarrhea. Dysarthria and irritability were
also evident. He had long-standing diabetes mellitus that
had been well controlled with metformin. His vital signs
were normal except for pyrexia (temperature of 38.5 °C).
Laboratory tests demonstrated leukopenia, thrombocy
topenia, hyponatremia, and increased levels of aspartate
aminotransferase (AST), alanine aminotransferase (ALT),
lactate dehydrogenase (LDH), and creatine kinase (CK).
Brain MRI revealed a hyperintense lesion in the SCC on
T2- (Fig. 1a) and diffusion-weighted (DW) (Fig. 1b) image
sequences. A preliminary diagnosis of cerebral infarction
was made, and intravenous administration of edaravone
was started. However, his clinical condition had not
improved by the 3rd day after illness onset, and he was,
therefore, transferred to our hospital.
On admission, our patient’s Glasgow score (GCS)
was 12 (E3, V3, M6), and he showed limb tremor and
scanning speech. A tick bite wound was observed on
the anterior aspect of his right ankle.
Blood tests showed leukopenia with a shift to the left,
2.8 × 109/L (normal range: 4.0–9.0) with 48% bands and
1% of atypical lymphocyte.
The other laboratory tests yielded the following results:
platelet count, 59 × 109/L (150–450); and hemoglobin,
14.7 g/dL (12–16); C-reactive protein, 1.51 mg/dL (0–0.3);
AST, 159 U/L (13–33); ALT, 59 U/L (8–42); LDH, 429 U/
L (100–200); creatinine, 1.21 mg/dL (0.36–1.06); CK, 2559
U/L (62–287); serum ferritin, 1980 U/mL (122–496); and
sodium levels, 129 mmol/L (135–149).
Contrast-enhanced whole-body computed tomography
revealed slight enlargement of the mediastinal, axillary,
and inguinal lymph nodes. On the 5th day of illness,
reverse-transcription polymerase chain reaction (RT-
PCR) for SFTS virus (SFTSV) using a blood sample had
a positive result, confirming that our patient had SFTSV
infection (Fig. 2).
The laboratory values on that day were as follows:
platelet count, 31 × 109/L; fibrin/fibrinogen degradation
products (FDP), 49.0 μg/mL (0–1); soluble CD25, 2402
U/mL: and increases in the AST, LDH, CK, and serum
ferritin levels to 159 U/L, 429 U/L, 4016 U/L, and 24667
U/mL, respectively. A bone marrow smear showed mild
hemophagocytosis (Fig. 3).
These laboratory findings fulfilled the diagnostic cri-
teria for acute disseminated intravascular coagulation
(DIC) [9] and the clinical diagnosis of secondary hemo-
phagocytic lymphohistiocytosis (HLH) was made by the
revised diagnostic criteria including fever, bicytopenia,
hepatitis, high level of serum ferritin and sIL-2R, and
hemophagocytosis in bone marrow [10].
Thereafter, our patient’s CNS manifestations deterio-
rated, and he exhibited convulsion and stupor as well
Fig. 1 T2- and diffusion-weighted images. T2-weighted (a) and diffusion-weighted (b) brain magnetic resonance images on the 2nd day showing
high-intensity lesions in the splenium of the corpus callosum (arrow). The splenial lesions had completely disappeared on the 5th day (c)
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as hemorrhagic manifestations, such as gingival bleeding
and melena. Lumbar puncture was not performed due to
DIC. However, a follow-up DW brain MRI scan on the 5th
day of illness demonstrated complete disappearance of the
SCC signal enhancement (Fig. 1c).
Laboratory findings indicated gradual improvement
after the 6th day of illness. Moreover, hemorrhagic mani-
festations disappeared on the 9th day of illness, and the
CNS disturbance was resolved by the 16th day. Our
patient was discharged on the 24th day after illness onset
with an overall improvement in his condition. We
treated our patient with symptomatic and supportive
measures. Throughout the course, our patient neither
required intensive care nor was treated with the adminis-
tration of corticosteroids. He was treated with fluid
replacement for dehydration and platelet transfusion. The
clinical findings are summarized in Table 1.
The SFTS viral load in serum samples collected from
our patient, on days 1, 3, 5, 7, 11, and 14 after illness
onset were determined by quantitative RT-PCR (qRT-
PCR), as described previously [11, 12]. On admission,
there had been 2.8 × 105 copies/mL, but the viral load
rapidly decreased during the remaining period of
hospitalization (Fig. 2).
Discussion
We have reported the case of a severely ill patient with
SFTSV-associated encephalitis/encephalopathy in whom
an SCC lesion was detected, but showed spontaneous
resolution. The presence of a reversible SCC lesion has
been reported in patients with a broad spectrum of dis-
eases and conditions, and is referred to as RESLES [3].
Infection is the most common cause of this abnormality.
To the best of our knowledge, this is the first reported
case of RESLES in a patient with SFTSV infection.
The common neurological symptoms of RESLES asso-
ciated with encephalitis/encephalopathy may include
delirium, short-term disturbance of consciousness, and
seizures, but usually patients show complete recovery
without neurological sequelae after a short disease
course [13, 14]. Although CNS manifestations are com-
mon in patients with SFTS, signs of severe CNS disturb-
ance, such as coma and convulsion, are thought to be
major clinical indicators of poor prognosis [2]. An epide-
miologic study of 538 patients with SFTS revealed that
19.1% of them developed encephalitis and 44.7% of the
19.1% died [15].
In the present case, it was not clear whether the severe
CNS disturbance was due to the severe clinical course of
SFTS itself or the SCC lesion that developed secondarily.
Achalia et al. speculated that the prognosis of RESLES
may depend on the underlying disorder and not on
other factors [16]. The worsening CNS manifestations,
hemorrhagic manifestations, and laboratory data in the
present patient were consistent with severe SFTSV infec-
tion. HLH may also have contributed to disease severity
and clinical outcome [17]. HLH results from excessive
activation of the immune system, leading to uncontrolled
cytokine release. Although the mechanism responsible for
reversible SCC lesions is unknown, Tada et al. postulated
that intra-myelinic edema or an inflammatory infiltrate
might account for the transient decrease in the ADC value
[4]. In the present case, we suspect that an inflammatory
infiltrate caused by cytokine cascades under conditions of
HLH may have been involved in the pathogenesis of the
reversible SCC lesion.
SFTS patients with severe complications such as
secondary HLH often receive corticosteroids, which
repress immune functions. SFTS patients are somewhat
immunodeficient [18] or have damaged immune
systems with low levels of CD3+ and CD4+ T
Fig. 2 Change in the severe fever with thrombocytopenia syndrome
viral copy numbers in the serum of the present patient. The viral
copy number on the 1st day after the onset of illness was 2.8 × 105
copies/mL and then rapidly decreased during the remaining period
of hospitalization. The horizontal dashed line indicates the median
detection limit for the quantitative reverse-transcription polymerase
chain reaction assays (0.43 × 103 copies/mL). RNA, ribonucleic acid
Fig. 3 Microscopic findings under May-Giemsa staining.
Hemophagocytosis is present in the bone marrow (×1000)
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lymphocytes [19, 20], which may be due to a viral-
associated hemophagocytic syndrome. Such immuno-
deficiency has an important role in disease progression,
disease severity, and clinical outcome. Therefore, the
administration of corticosteroids for the treatment of
HLH, is controversial, because it sometimes worsens
the infectious disease status including causing oppor-
tunistic infections. In fact, some lethal SFTS cases have
involved patients with a history of early treatment with
dexamethasone. In particular, two autopsy cases of
Japanese SFTS patients, who received corticosteroids
for hemophagocytosis, complicated by Aspergillus or
Mucor infection were reported [21]. It is noteworthy
that in the patient with Aspergillus infection, the
thrombocytopenia and other organ pathologies were
improving, although the aggressive pulmonary aspergil-
losis exacerbated the clinical course and resulted in
death in the patient. Because the use of corticosteroids
in severely ill SFTS patients may be possible to induce
opportunistic infections, a prospective study is needed
to evaluate the efficacy of corticosteroid therapy.
It appears that SFTS viral load is related to morbidity
[12]. It has been reported that the SFTS viral load in
acute-phase peripheral blood samples was significantly
higher in patients who died than in those who survived,
and that a high titer of ≥108 copies/mL led to fatal
outcomes [18, 22]. The mean viral load in the survivor
group was 105 copies/mL, which were consistent with
the findings reported by Zhang et al. [18]. Thus, there is
a possibility that in this case report the serum SFTS viral
load elevation on admission we see, which was equiva-
lent to that in the survivors reported by Zhang et al.,
contributed to the favorable outcome, even though the
patient was severely ill. Therefore, a rapid decline in the
viral load revealed by periodic monitoring may be useful
in predicting the outcome in severely ill patients with
SFTS.
Conclusions
The present case suggests that SFTSV infection can trigger
reversible SCC lesions. Even if patients show unexpectedly
severe and prolonged CNS disturbance during SFTS pro-
gression, monitoring of the serum SFTS viral load in the
acute phase may reveal a rapid decline that is predictive of
a favorable outcome and may enable the avoidance of the
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Table 1 Laboratory findings of the presented case of severe fever with thrombocytopenia syndrome (SFTS)
Laboratory findings Reference
range
Days after illness onset
2 3 5 6 9 15 19
WBC (×109/L) 4.0–9.0 1.4 2.8 2.63 3.19 4.36 5.95 6
Hemoglobin (g/dL) 12–16 (men) 15.3 14.7 16.4 16.4 11.4 11.6 10.7
Platelets (×109/L) 150–450 86 59 31 17 30 205 342
AST (U/L) 13–33 145 159 628 362 131 40 28
ALT (U/L) 8–42 55 59 125 93 96 44 27
LDH (U/L) 100–200 360 429 1611 1128 472 326 189
Amylase (U/L) 33–120 NA 116 279 314 179 107 107
Lipase (U/L) 13–49 NA NA 421 896 297 117 117
CRP (mg/dL) 0–0.3 NA 1.51 6.09 NA NA 1.21 NA
Creatinine (mg/dL) 0.36–1.06 1.29 1.21 1.35 1.14 0.69 0.71 0.71
CK (U/L) 62–287 2276 2559 4016 4912 699 113 65
CK-MB (U/L) 0–24 NA 37 69 NA NA NA NA
Ferritin (U/mL) 122–496 NA 1980 24667 NA 2209 413 413
Sodium (mmol/L) 135–149 125 129 137 143 137 NA 140
PT/INR 0.8–1.3 1.09 0.95 1.08 NA NA NA 0.91
aPTT (s) 24–36 59.1 40.9 100 NA NA 32.6 32.6
FDP (μg/mL) 0–5 NA NA 40.5 NA 2.5 NA 3.1
D-dimer (μg/mL) 0–1 NA 2.9 15.6 NA NA NA 2.3
Urine protein (mg/day) 684 NA 3845 3260 53163 813 685
NA not available, WBC white blood cells, AST aspartate aminotransferase, ALT alanine aminotransferase, LDH lactate dehydrogenase, CRP C-reactive protein, CK
creatine kinase, PT/INR prothrombin time/international normalized ratio, aPTT activated partial thromboplastin time, FDP fibrin/fibrinogen degradation products
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